secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARYA Sciences Acquisition Corp V (—)
CIK:        0001852432
Form:       8-K
Filed at:   2023-04-11T23:59:59+00:00
Accession:  0001140361-23-017819
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

ARYA Sciences SPAC restates Q3 2022 financials, cites accounting error on deferred commissions
--------------------------------------------------------------------------------

- Received underwriter waiver of 50% deferred commissions on Aug 8, 2022; previously recognized as extinguishment gain, now as credit to shareholders' deficit.
- Restatement covers Q3 2022 (Sept 30, 2022); no impact on cash, trust investments, operating expenses, or cash flows.
- Material weakness in internal control over financial reporting and ineffective disclosure controls identified for affected period.
- Audit Committee concluded on April 11, 2023 that prior statements should no longer be relied upon; restatement to be filed in 2022 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1852432/000114036123017819/0001140361-23-017819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1852432/000114036123017819/brhc10051185_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-017819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer